1. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy
- Author
-
Van Marter, Linda J., Leviton, Alan, Allred, Elizabeth N., Pagano, Marcello, Sullivan, Kathleen F., Cohen, Aaron, and Epstein, Michael F.
- Subjects
Persistent fetal circulation syndrome -- Risk factors ,Smoking -- Health aspects ,Aspirin -- Health aspects ,Nonsteroidal anti-inflammatory drugs -- Health aspects - Abstract
Taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy may predispose infants to developing persistent pulmonary hypertension of the newborn (PPHN). PPHN causes respiratory failure in otherwise normal full-term infants. NSAIDs and aspirin inhibit prostaglandin production, which animal studies have revealed can cause lung circulation complications after birth. Researchers interviewed mothers of 103 infants with PPHN who were of normal weight at birth and free of congenital anomalies and compared their responses with mothers of 298 matched healthy infants. Mothers of infants with PPHN were five times more likely to have taken aspirin and six times more likely to have taken NSAIDs. Mothers who smoked were twice as likely to have infants with PPHN; however, the effects of smoking could not be distinguished statistically from the effects of low maternal education and illicit drug use. Smoking could predispose infants to PPHN because it causes chronic oxygen lack, another factor animal studies have shown to cause lung circulation complications., Objective. Prenatal causation of persistent pulmonary hypertension of the newborn (PPHN) is suggested by a specific pattern of pulmonary vascular remodeling observed immediately after birth in some infants with fatal PPHN. The goal of this study was to determine whether PPHN is associated with fetal exposure to: (1) tobacco and marijuana smoking (ie, contributors to fetal hypoxemia), (2) consumption of aspirin and other nonsteroidal antiinflammatory drugs (ie, inhibitors of prostaglandin synthesis), and (3) cocaine use (ie, a contributor to vasospasm). Design. Case-control interview study. Setting. Two Harvard-affiliated newborn intensive care units. Participants. Mothers of case infants who had PPHN or who met criteria for the referent group. Interventions. During July 1985 through April 1989, we interviewed mothers of 103 infants with PPHN and 298 control infants. Because of potential selection bias that might result from recruiting only inborn control infants even though two-thirds of cases were outborn, separate analyses compared the 103 total and 35 inborn infants with PPHN with the 298 inborn control infants. Multivariate analyses were used to adjust for potential confounding factors, including maternal education and Medicaid health insurance (ie, two markers of socioeconomic status), other antenatal factors found to be associated with PPHN (ie, maternal urinary tract infection and diabetes mellitus), and the infant's sex. Main Outcome Measures. Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy. Results. The adjusted odds ratios (and 95% confidence intervals) for maternal pregnancy exposures to the factors of principal interest among the total study population were: aspirin, 4.9 (1.6-15.3); and nonsteroidal antiinflammatory drugs, 6.2 (1.8-21.8); for the inborn group they were: aspirin, 9.6 (2.4-39.0); and nonsteroidal antiinflammatory drugs, 17.5 (4.3-71.6). Although the association between tobacco smoking during pregnancy and PPHN was elevated in univariate analyses, with odds ratios (and 95% confidence intervals) of 2.0 (1.2-3.4) and 1.3 (0.6-3.3) for total and inborn populations, respective the relationship was not significant after adjustment for all other factors in the final logistic regression model. Acknowledged illicit drug use was too infrequent (3.2%) to evaluate. Conclusion. Maternal consumption of nonsteroidal antiinflammatory drugs and aspirin during pregnancy or the reasons these drugs were ingested seem to contribute to an increased risk of PPHN. Pediatrics 1996;97:658 - 663; newborn infant, diseases; hypertension, pulmonary, persistent fetal circulation, aspirin; nonsteroidal antiinflammatory drugs; smoking; drug abuse; socioeconomic status; diabetes mellitus. ABBREVIATIONS. PPHN, persistent pulmonary hypertension of the newborn; NSAID, nonsteroidal antiinflammatory drug; ECMO, extracorporeal membrane oxygenation; OR, odds ratio; UTI, urinary tract infection; SES, socioeconomic status., Persistent pulmonary hypertension of the newborn (PPHN) is an important cause of profound respiratory failure in newborns, occurring at a rate of 1 in 600 to 1 in 1500 live [...]
- Published
- 1996